Transcriptional cancers cdk6. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy13

Cell Line, Tumor Tumor Cells, Cultured Neoplastic Stem Cells Breast HCT116 Cells Cell Line Prostate MCF-7 Cells HT29 Cells HeLa Cells Cell Nucleus Epithelial Cells Cells, Cultured

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases45

Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Invasiveness Neoplasm Metastasis Neoplasms Pancreatic Neoplasms Uterine Cervical Neoplasms Genetic Predisposition to Disease Carcinoma, Squamous Cell Carcinoma Disease Progression Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Colorectal Neoplasms Cell Transformation, Neoplastic Rectal Neoplasms Neoplasm Recurrence, Local Endometrial Neoplasms Esophageal Neoplasms Liver Neoplasms Adenocarcinoma Neoplasms, Hormone-Dependent Head and Neck Neoplasms Mouth Neoplasms Carcinoma, Small Cell Bone Neoplasms Skin Neoplasms Neoplasms, Radiation-Induced Neoplasms, Second Primary Neovascularization, Pathologic Neoplasms, Glandular and Epithelial Precancerous Conditions Genital Neoplasms, Female Gastrointestinal Neoplasms Mammary Neoplasms, Experimental Thyroid Neoplasms Melanoma Neoplasms, Multiple Primary Pharyngeal Neoplasms Disease Models, Animal Kidney Neoplasms

Chemicals and Drugs72

Cyclin-Dependent Kinases Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinase 4 CDC2-CDC28 Kinases Cyclin-Dependent Kinase 6 Cancer Vaccines Neoplasm Proteins CDC2 Protein Kinase Cyclins Antineoplastic Agents Cell Cycle Proteins Protein-Serine-Threonine Kinases RNA, Messenger Cyclin-Dependent Kinase Inhibitor p27 Tumor Suppressor Proteins Receptors, Estrogen RNA, Small Interfering Tumor Markers, Biological Cyclin E Tumor Suppressor Protein p53 Cyclin-Dependent Kinase 9 Receptor, erbB-2 Proto-Oncogene Proteins DNA, Neoplasm Cyclin D1 Prostate-Specific Antigen Cyclin-Dependent Kinase Inhibitor p21 Tamoxifen Fluorouracil Antineoplastic Agents, Phytogenic Cisplatin Nuclear Proteins Receptors, Progesterone Antineoplastic Agents, Hormonal Antigens, Neoplasm DNA-Binding Proteins Anticarcinogenic Agents Protein Kinase Inhibitors Enzyme Inhibitors Cyclin-Dependent Kinase 8 Paclitaxel Transcription Factors Cyclin D Cyclin-Dependent Kinase Inhibitor p16 MicroRNAs Receptor, Epidermal Growth Factor Antibodies, Monoclonal Purines Deoxycytidine Microtubule-Associated Proteins Receptors, Androgen RNA, Neoplasm Antimetabolites, Antineoplastic Cyclin B Taxoids Proto-Oncogene Proteins c-akt Cyclin H BRCA2 Protein Carcinogens Androgens BRCA1 Protein Estrogens Cyclin B1 Antibodies, Monoclonal, Humanized Carrier Proteins Cyclin D3 DNA Primers Oncogene Proteins Estrogen Receptor alpha Proto-Oncogene Proteins c-bcl-2 Quinazolines

Analytical, Diagnostic and Therapeutic Techniques and Equipment61

Early Detection of Cancer Survival Analysis Survival Rate Reverse Transcriptase Polymerase Chain Reaction Prognosis Antineoplastic Combined Chemotherapy Protocols Blotting, Western Gene Expression Profiling Risk Xenograft Model Antitumor Assays Follow-Up Studies Retrospective Studies Registries Prospective Studies Neoplasm Staging Risk Assessment Neoplasm Transplantation Disease-Free Survival Combined Modality Therapy Odds Ratio Transfection Transplantation, Heterologous Chemotherapy, Adjuvant Oligonucleotide Array Sequence Analysis Sensitivity and Specificity Models, Biological Drug Screening Assays, Antitumor Kaplan-Meier Estimate Mammography Multivariate Analysis Risk Factors Polymerase Chain Reaction Tumor Burden Questionnaires SEER Program Molecular Targeted Therapy Clinical Trials as Topic Flow Cytometry Gene Knockdown Techniques Predictive Value of Tests Logistic Models Reproducibility of Results Neoplasm Grading Radiotherapy Tissue Array Analysis Confidence Intervals Immunoenzyme Techniques Mammary Neoplasms, Experimental Drug Administration Schedule Incidence Palliative Care Mastectomy Treatment Outcome DNA Mutational Analysis Genetic Testing Biopsy Immunotherapy Disease Models, Animal Immunoblotting Radiotherapy, Adjuvant Real-Time Polymerase Chain Reaction

Psychiatry and Psychology1

Phenomena and Processes52

Cell Cycle Gene Expression Regulation, Neoplastic Phosphorylation Mutation Genetic Predisposition to Disease Drug Resistance, Neoplasm Risk Cell Division G1 Phase Down-Regulation Cell Proliferation Cell Survival Apoptosis Odds Ratio DNA Methylation Transfection Cell Movement RNA Interference Promoter Regions, Genetic Genotype Sensitivity and Specificity Cell Growth Processes Genes, BRCA1 S Phase Dose-Response Relationship, Drug Signal Transduction Up-Regulation Polymorphism, Genetic Base Sequence Genes, Tumor Suppressor Gene Silencing Protein Binding Germ-Line Mutation Mitosis Gene Expression Enzyme Activation Genes, p53 Phenotype Transcription, Genetic Genes, Neoplasm DNA Damage Postmenopause Diet Genes, BRCA2 Amino Acid Sequence Alleles Drug Synergism Epithelial-Mesenchymal Transition G2 Phase Gene Amplification Genes, ras Epigenesis, Genetic

Disciplines and Occupations1

Medical Oncology

Anthropology, Education, Sociology and Social Phenomena2

National Cancer Institute (U.S.)Quality of Life

Humanities1

Quality of Life

Information Science8

Survival Rate Registries Molecular Sequence Data Questionnaires SEER Program Base Sequence Incidence Amino Acid Sequence

Named Groups2

Survivors European Continental Ancestry Group

Health Care28

Survival Analysis Survival Rate National Cancer Institute (U.S.)Risk Follow-Up Studies Retrospective Studies Registries Prospective Studies Risk Assessment Disease-Free Survival Age Factors Odds Ratio Sensitivity and Specificity Kaplan-Meier Estimate Multivariate Analysis Risk Factors Questionnaires SEER Program Clinical Trials as Topic American Cancer Society Predictive Value of Tests Logistic Models Reproducibility of Results Confidence Intervals Incidence Palliative Care Treatment Outcome Genetic Testing

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Cyclin-Dependent Kinases Early Detection of Cancer Cyclin-Dependent Kinase 2 Cyclin-Dependent Kinase 5 Cyclin-Dependent Kinase 4 Prostatic Neoplasms Ovarian Neoplasms Breast Neoplasms Lung Neoplasms Colonic Neoplasms Stomach Neoplasms CDC2-CDC28 Kinases Cell Cycle Neoplasm Invasiveness Neoplasm Metastasis Gene Expression Regulation, Neoplastic Neoplasms Pancreatic Neoplasms Mice, Nude Cyclin-Dependent Kinase 6 Cancer Vaccines Neoplasm Proteins CDC2 Protein Kinase Cell Line, Tumor Cyclins Phosphorylation Antineoplastic Agents Cell Cycle Proteins Uterine Cervical Neoplasms Mutation Survival Analysis Genetic Predisposition to Disease Survival Rate Protein-Serine-Threonine Kinases Reverse Transcriptase Polymerase Chain Reaction Drug Resistance, Neoplasm Prognosis Carcinoma, Squamous Cell RNA, Messenger Carcinoma Antineoplastic Combined Chemotherapy Protocols Disease Progression Urinary Bladder Neoplasms Carcinoma, Non-Small-Cell Lung Blotting, Western National Cancer Institute (U.S.)Gene Expression Profiling Risk Cyclin-Dependent Kinase Inhibitor p27 Xenograft Model Antitumor Assays Tumor Suppressor Proteins Colorectal Neoplasms Follow-Up Studies Receptors, Estrogen RNA, Small Interfering Retrospective Studies Cell Division Tumor Markers, Biological Cyclin E Registries Tumor Suppressor Protein p53 Cyclin-Dependent Kinase 9 Cell Transformation, Neoplastic Prospective Studies Receptor, erbB-2 Neoplasm Staging G1 Phase Survivors Proto-Oncogene Proteins Risk Assessment United States Rectal Neoplasms Neoplasm Recurrence, Local Down-Regulation Cell Proliferation DNA, Neoplasm Neoplasm Transplantation Cell Survival Disease-Free Survival Cyclin D1 Apoptosis Endometrial Neoplasms Combined Modality Therapy Prostate-Specific Antigen Cyclin-Dependent Kinase Inhibitor p21 Age Factors Odds Ratio DNA Methylation Transfection Tamoxifen Smoking Transplantation, Heterologous Chemotherapy, Adjuvant Tumor Cells, Cultured Esophageal Neoplasms Cell Movement RNA Interference Fluorouracil Antineoplastic Agents, Phytogenic Molecular Sequence Data

No FAQ available that match "transcriptional cancers cdk6"